Experimental Hematology

Papers
(The TQCC of Experimental Hematology is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-06-01 to 2024-06-01.)
ArticleCitations
Stress erythropoiesis: definitions and models for its study54
Simplified murine multipotent progenitor isolation scheme: Establishing a consensus approach for multipotent progenitor identification43
Hand in hand: intrinsic and extrinsic drivers of aging and clonal hematopoiesis42
Yin and Yang: The dual effects of interferons on hematopoiesis41
Efficacy and safety of recently approved drugs for sickle cell disease: a review of clinical trials41
Periodontitis and circulating blood cell profiles: a systematic review and meta-analysis40
Erythroid enucleation: a gateway into a “bloody” world33
Sirolimus is effective for primary relapsed/refractory autoimmune cytopenia: a multicenter study33
Mechanisms of lenalidomide sensitivity and resistance28
The erythroblastic island niche: modeling in health, stress, and disease28
Hypoxia promotes erythroid differentiation through the development of progenitors and proerythroblasts27
“Caught in the net”: the extracellular matrix of the bone marrow in normal hematopoiesis and leukemia24
Analysis of IL-6 serum levels and CAR T cell-specific digital PCR in the context of cytokine release syndrome22
Single-cell insights into the hematopoietic generation of T-lymphocyte precursors in mouse and human21
Hematopoietic stem and progenitor cells outside the bone marrow: where, when, and why21
TIFA and TIFAB: FHA-domain proteins involved in inflammation, hematopoiesis, and disease20
Lineage commitment of hematopoietic stem cells and progenitors: insights from recent single cell and lineage tracing technologies20
Does lineage plasticity enable escape from CAR-T cell therapy? Lessons from MLL-r leukemia19
The RUNX1/RUNX1T1 network: translating insights into therapeutic options18
A sticky wicket: Defining molecular functions for CD34 in hematopoietic cells17
Anti-CD117 immunotherapy to eliminate hematopoietic and leukemia stem cells16
The Akt–mTOR network at the interface of hematopoietic stem cell homeostasis16
Interleukin 7 receptor is required for myeloid cell homeostasis and reconstitution by hematopoietic stem cells15
Hematopoietic stem cell gene editing and expansion: State-of-the-art technologies and recent applications15
Human CD34-negative hematopoietic stem cells: The current understanding of their biological nature14
AML chemoresistance: The role of mutant TP53 subclonal expansion and therapy strategy13
Understanding of the crosstalk between normal residual hematopoietic stem cells and the leukemic niche in acute myeloid leukemia13
Interaction of the inflammatory response and megakaryocytes in COVID-19 infection12
VEGF, FGF2, and BMP4 regulate transitions of mesoderm to endothelium and blood cells in a human model of yolk sac hematopoiesis12
Regulation of CD71+TER119+ erythroid progenitor cells by CD4512
Buffering noise: KAT2A modular contributions to stabilization of transcription and cell identity in cancer and development12
Single-cell technologies and analyses in hematopoiesis and hematological malignancies11
Challenges of chimeric antigen receptor T-cell therapy in chronic lymphocytic leukemia: lessons learned11
HOXA9/IRX1 expression pattern defines two subgroups of infant MLL-AF4-driven acute lymphoblastic leukemia11
Transcriptional differences between JAK2-V617F and wild-type bone marrow cells in patients with myeloproliferative neoplasms11
Engineering human hematopoietic environments through ossicle and bioreactor technologies exploitation10
Reading the B-cell receptor immunome in chronic lymphocytic leukemia: revelations and applications10
Molecular Basis of Hematological Disease Caused by Inherited or Acquired RUNX1 Mutations10
MNDA controls the expression of MCL-1 and BCL-2 in chronic lymphocytic leukemia cells10
Erythropoietin is a major regulator of thrombopoiesis in thrombopoietin-dependent and -independent contexts10
Cyclosporine enhances the sensitivity to lenalidomide in MDS/AML in vitro10
Preclinical evaluation of JAK1/2 inhibition by ruxolitinib in a murine model of chronic graft-versus-host disease10
Mitochondria in human acute myeloid leukemia cell lines have ultrastructural alterations linked to deregulation of their respiratory profiles10
Role of Rap1 in DNA damage response: implications in stem cell homeostasis and cancer9
Perspective: sensitive detection of residual lymphoproliferative disease by NGS and clonal rearrangements—how low can you go?9
Anti-CD20 monoclonal antibodies inhibit seropositive response to Covid-19 vaccination in non-Hodgkin lymphoma patients within 6 months after treatment9
Salvianolic acid A inhibits the growth of diffuse large B-cell lymphoma through MAPK pathways9
Stayin’ alive: BCL-2 proteins in the hematopoietic system9
Gene expression changes contribute to stemness and therapy resistance of relapsed acute myeloid leukemia: roles of SOCS2, CALCRL, MTSS1, and KDM6A9
Recent advances in T-cell lymphoid neoplasms9
TLR7/8 agonist treatment induces an increase in bone marrow resident dendritic cells and hematopoietic progenitor expansion and mobilization9
Evolving insights on histone methylome regulation in human acute myeloid leukemia pathogenesis and targeted therapy9
Arid2 regulates hematopoietic stem cell differentiation in normal hematopoiesis9
Eflapegrastim's enhancement of efficacy compared with pegfilgrastim in neutropenic rats supports potential for same-day dosing9
Macrophages form erythropoietic niches and regulate iron homeostasis to adapt erythropoiesis in response to infections and inflammation9
Beyond “to divide or not to divide”: Kinetics matters in hematopoietic stem cells8
Inhibition of TGFβ1 and TGFβ3 promotes hematopoiesis in Fanconi anemia8
CRISPR–Cas9 gene editing induced complex on-target outcomes in human cells8
Two faces of RUNX3 in myeloid transformation8
Cotargeting of Bcl-2 and Mcl-1 shows promising antileukemic activity against AML cells including those with acquired cytarabine resistance8
Pseudogenes and their potential functions in hematopoiesis8
Role of macrophages and phagocytes in orchestrating normal and pathologic hematopoietic niches8
Combination of azacitidine and enasidenib enhances leukemic cell differentiation and cooperatively hypomethylates DNA8
Probable HLA-mediated immunoediting of JAK2 V617F-driven oncogenesis8
Effect of Clonal Hematopoiesis on Cardiovascular Disease in People Living with HIV8
TBL1X: At the crossroads of transcriptional and posttranscriptional regulation8
TLR2/6 signaling promotes the expansion of premalignant hematopoietic stem and progenitor cells in the NUP98–HOXD13 mouse model of MDS8
Visible and near-infrared hyperspectral imaging techniques allow the reliable quantification of prognostic markers in lymphomas: A pilot study using the Ki67 proliferation index as an example8
Iron-loaded transferrin potentiates erythropoietin effects on erythroblast proliferation and survival: a novel role through transferrin receptors8
Distinct effects of chondroitin sulfate on hematopoietic cells and the stromal microenvironment in bone marrow hematopoiesis8
Programmed necroptosis is upregulated in low-grade myelodysplastic syndromes and may play a role in the pathogenesis8
Human pediatric B-cell acute lymphoblastic leukemias can be classified as B-1 or B-2-like based on a minimal transcriptional signature7
Recurrent transcriptional responses in AML and MDS patients treated with decitabine7
Toll-like receptor and cytokine expression throughout the bone marrow differs between patients with low- and high-risk myelodysplastic syndromes7
Detection of chemotherapy-resistant patient-derived acute lymphoblastic leukemia clones in murine xenografts using cellular barcodes7
Loss-of-function mutations in BCOR contribute to chemotherapy resistance in acute myeloid leukemia7
CFU-S assay: a historical single-cell assay that offers modern insight into clonal hematopoiesis7
Enhancing mitochondrial function in vivo rescues MDS-like anemia induced by pRb deficiency7
DEPTOR is a microRNA-155 target regulating migration and cytokine production in diffuse large B-cell lymphoma cells7
Metformin-induced suppression of Nemo-like kinase improves erythropoiesis in preclinical models of Diamond–Blackfan anemia through induction of miR-26a7
Intrinsically magnetic susceptibility in human blood and its potential impact on cell separation: Non-classical and intermediate monocytes have the strongest magnetic behavior in fresh human blood7
Mechanisms of resistance to targeted therapies for relapsed or refractory acute myeloid leukemia6
Signal-transducing adaptor protein-1 and protein-2 in hematopoiesis and diseases6
A high prevalence of myeloid malignancies in progeria with Werner syndrome is associated with p53 insufficiency6
Dnmt3a-null hematopoietic stem and progenitor cells expand after busulfan treatment6
Quantitative Analysis of Sympathetic and Nociceptive Innervation Across Bone Marrow Regions in Mice6
Lipid uptake in chronic lymphocytic leukemia6
C/EBPβ sustains the oncogenic program of AML cells by cooperating with MYB and co-activator p300 in a transcriptional module6
Germline ETV6 mutation promotes inflammation and disrupts lymphoid development of early hematopoietic progenitors6
Dynamics of human hematopoietic stem and progenitor cell differentiation to the erythroid lineage6
Feeder-free and serum-free in vitro assay for measuring the effect of drugs on acute and chronic myeloid leukemia stem/progenitor cells6
miR-495-3p sensitizes BCR-ABL1-expressing leukemic cells to tyrosine kinase inhibitors by targeting multidrug resistance 1 gene in T315I mutated cells6
Integrins and their role in megakaryocyte development and function6
KDM6A, a histone demethylase, regulates stress hematopoiesis and early B-cell differentiation6
Engineering of targeted megabase-scale deletions in human induced pluripotent stem cells6
Single-cell analysis of erythropoiesis in Rpl11 haploinsufficient mice reveals insight into the pathogenesis of Diamond–Blackfan anemia6
Hematopoietic stem cell (HSC) divisional memory: The journey of mitochondrial metabolism through HSC division6
ZFP36L1 plays an ambiguous role in the regulation of cell expansion and negatively regulates CDKN1A in chronic myeloid leukemia cells5
Is extra-embryonic endoderm a source of placental blood cells?5
The SLAMF3 rs509749 polymorphism correlates with malignant potential in multiple myeloma5
hnRNPK/Beclin1 signaling regulates autophagy to promote imatinib resistance in Philadelphia chromosome-positive acute lymphoblastic leukemia cells5
The old and the new: DNA and RNA methylation in normal and malignant hematopoiesis5
HSC-derived fatty acid oxidation in steady-state and stressed hematopoiesis5
Serum metabolomic profiling correlated with ISS and clinical outcome for multiple myeloma patients treated with high-dose melphalan and autologous stem cell transplantation5
Chronic inflammation can transform the fate of normal and mutant hematopoietic stem cells5
Function of the P2X7 receptor in hematopoiesis and leukemogenesis5
Control of fetal globin expression in man: new opportunities to challenge past discoveries5
Chronic lymphocytic leukemia–like monoclonal B-cell lymphocytosis exhibits an increased inflammatory signature that is reduced in early-stage chronic lymphocytic leukemia5
Residual effects of busulfan and irradiation on murine hematopoietic stem and progenitor cells5
Reticulocyte mitochondrial retention increases reactive oxygen species and oxygen consumption in mouse models of sickle cell disease and phlebotomy-induced anemia5
Transcriptional reprogramming in neonatal hematopoietic stem and progenitor cells5
Codanin-1 mutations engineered in human erythroid cells demonstrate role of CDAN1 in terminal erythroid maturation5
Role of ASXL1 in hematopoiesis and myeloid diseases5
miRNA-223-3p modulates ibrutinib resistance through regulation of the CHUK/Nf-κb signaling pathway in mantle cell lymphoma5
Ex Vivo Expansion of Phenotypic and Transcriptomic Chronic Myeloid Leukemia Stem Cells5
The regulation roles of Ca2+ in erythropoiesis: What have we learned?5
Overlooking the obvious? On the potential of treatment alterations to predict patient-specific therapy response5
How Hematopoietic Stem Cells Respond to Irradiation: Similarities and Differences between Low and High Doses of Ionizing Radiations5
Human, mouse, and dog bone marrow show similar mesenchymal stromal cells within a distinctive microenvironment4
Translational research for bone marrow failure patients4
The transcription factor NFE2 enhances expression of the hematopoietic master regulators SCL/TAL1 and GATA24
RUNX1 Inhibition Using Lipid Nanoparticle-Mediated Silencing RNA Delivery as an Effective Treatment for Acute Leukemias4
AMD3100 redosing fails to repeatedly mobilize hematopoietic stem cells in the nonhuman primate and humanized mouse4
The delta isoform of phosphatidylinositol-3-kinase predominates in chronic myelomonocytic leukemia and can be targeted effectively with umbralisib and ruxolitinib4
Differential expression of hydroxyurea transporters in normal and polycythemia vera hematopoietic stem and progenitor cell subpopulations4
Erythropoietin regulates metabolic response in mice via receptor expression in adipose tissue, brain, and bone4
Single-cell lineage tracing approaches in hematology research: technical considerations4
Apoptotic events induced by a natural plastoquinone from the marine alga Desmarestia menziesii in lymphoid neoplasms4
Radiation-free reduced-intensity hematopoietic stem cell transplantation with in vivo T-cell depletion from matched related and unrelated donors for Fanconi anemia: prognostic factor analysis4
MLLT10 in benign and malignant hematopoiesis4
Adult murine hematopoietic stem cells and progenitors: an update on their identities, functions, and assays4
How nutrition regulates hematopoietic stem cell features4
Humanized three-dimensional scaffold xenotransplantation models for myelodysplastic syndromes4
Single-cell analysis of cultured bone marrow stromal cells reveals high similarity to fibroblasts in situ4
α4-Integrin deficiency in human CD34+ cells engenders precocious erythroid differentiation but inhibits enucleation3
Microenvironment in acute myeloid leukemia: focus on senescence mechanisms, therapeutic interactions, and future directions3
Reproducibility of low-level residual myeloma immunoglobulin detection using ultra-deep sequencing3
Differential effects of Huaier aqueous extract on human CD4+T lymphocytes from patients with primary immune thrombocytopenia3
Transplantation of T-cell receptor α/β-depleted allogeneic bone marrow in nonhuman primates3
Extracellular vesicles tell all: How vesicle-mediated cellular communication shapes hematopoietic stem cell biology with increasing age3
Reduced IFN-γ levels along with changes in hematologic and immunologic parameters are key to COVID-19 severity in Bangladeshi patients3
CXCR4 and CD74 together enhance cell survival in response to macrophage migration-inhibitory factor in chronic lymphocytic leukemia3
Targeting elevated heme levels to treat a mouse model for Diamond-Blackfan Anemia3
Rapamycin inhibits the progression of human acute myeloid leukemia by regulating the circ_0094100/miR-217/ATP1B1 axis3
Cell competition between wild-type and JAK2V617F mutant cells in a murine model of a myeloproliferative neoplasm3
Efficacy of tyrosine kinase inhibitors on a mouse chronic myeloid leukemia model and chronic myeloid leukemia stem cells3
The critical role of germinal center-associated nuclear protein in cell biology, immunohematology, and hematolymphoid oncogenesis3
Avatrombopag is effective in patients with chemoradiotherapy-induced aplastic anemia: a single-center, retrospective study3
Downregulation of SATB1 by miRNAs reduces megakaryocyte/erythroid progenitor expansion in preclinical models of Diamond–Blackfan anemia3
Bone marrow transplantation without myeloablative conditioning in a mouse model for Diamond-Blackfan anemia corrects the disease phenotype3
Pacritinib protects dendritic cells more efficiently than ruxolitinib3
Physical interaction between BAALC and DBN1 induces chemoresistance in leukemia3
CD99 in malignant hematopoiesis3
Proteomic markers with prognostic impact on outcome of chronic lymphocytic leukemia patients under chemo-immunotherapy: results from the HOVON 109 study3
Variability in the cleavage of exosome-associated transferrin receptor questions the utility of clinically useful soluble transferrin receptor assays for dogs, cats, and horses3
Combination strategies to promote sensitivity to cytarabine-induced replication stress in acute myeloid leukemia with and without DNMT3A mutations3
Bortezomib enhances G-CSF-induced hematopoietic stem cell mobilization by decreasing CXCL12 levels and increasing vascular permeability3
Translatome changes in acute myeloid leukemia cells post exposure to pegcrisantaspase and venetoclax3
Megakaryocyte–stromal cell interactions: Effect on megakaryocyte proliferation, proplatelet production, and survival3
Heritable genetic background alters survival and phenotype of Mll-AF9-induced leukemias3
Immune composition and its association with hematologic recovery after chemotherapeutic injury in acute myeloid leukemia3
Relationship of T- and B-cell kinetics to clinical response in patients with relapsed/refractory non-Hodgkin lymphoma treated with blinatumomab3
The (intra-aortic) hematopoietic cluster cocktail: what is in the mix?3
Dynamic DNA methylation reveals novel cis-regulatory elements in mouse hematopoiesis3
Epigenetic maintenance strategies after allogeneic stem cell transplantation in acute myeloid leukemia3
3113 – FORTY-EIGHT WEEK EFFICACY AND SAFETY OF PEGCETACOPLAN IN ADULT PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA AND SUBOPTIMAL RESPONSE TO PRIOR ECULIZUMAB TREATMENT3
Mitochondrial Deep Dive into Hematopoietic Stem Cell Dormancy: Not Much Glycolysis but Plenty of Sluggish Lysosomes3
Combined G-CSF and Plerixafor enhance hematopoietic recovery of CD34+ cells from poor mobilizer patients in NSG mice3
Glucose-6-phosphate dehydrogenase is dispensable for human erythroid cell differentiation in vitro2
The impact of the chromatin binding DEK protein in hematopoiesis and acute myeloid leukemia2
An In Vivo Model for Elucidating the Role of an Erythroid-Specific Isoform of Nuclear Export Protein Exportin 7 (Xpo7) in Murine Erythropoiesis2
Generation of a lenalidomide-sensitive syngeneic murine in vivo multiple myeloma model by expression of Crbn2
Persistent expression of microRNA-125a targets is required to induce murine hematopoietic stem cell repopulating activity2
EGR1 Haploinsufficiency Confers a Fitness Advantage to Hematopoietic Stem Cells Following Chemotherapy2
RUNX1/ETO and mutant KIT both contribute to programming the transcriptional and chromatin landscape in t(8;21) acute myeloid leukemia2
Prognostic role of the ratio of natural killer cells to regulatory T cells in patients with multiple myeloma treated with lenalidomide and dexamethasone2
Ex vivo hematopoietic stem cell expansion technologies: recent progress, applications, and open questions2
5-Aza-dC promotes T-cell acute lymphoblastic leukemia cell invasion via downregulation of DNMT1 and upregulation of MMP-2 and MMP-92
Expanding hematopoietic stem cell ex vivo: recent advances and technical considerations2
MST1 downregulates TAZ tumor suppressor protein in multiple myeloma and is a potential therapeutic target2
Efficacy of chemotherapy protocols for hematological malignancies: H-CVAD versus GELA/BURKIMAB/PETHEMA LAL2
JQ-1/bortezomib combination strongly impairs MM and PEL survival by inhibiting c-Myc and mTOR despite the activation of prosurvival mechanisms2
EVI1 protein interaction dynamics: Targetable for therapeutic intervention?2
ZBTB7A links tumor metabolism to myeloid differentiation2
From cell to cell: Identification of actionable targets in bone marrow fibrosis using single-cell technologies2
A phase 1/2 study of ixazomib in place of bortezomib or carfilzomib in a subsequent line of therapy for patients with multiple myeloma refractory to their last bortezomib or carfilzomib combination re2
The multifaceted role of mitochondria in HSC fate decisions: energy and beyond2
3142 – GLUCOCORTICOID-INDUCED LEUCINE ZIPPER (GILZ) INTRINSICALLY REGULATES HEMATOPOIETIC STEM CELL FUNCTION2
Inhibition of CXCR1/2 reduces the emperipolesis between neutrophils and megakaryocytes in the Gata1low model of myelofibrosis2
New insight into the causes, consequences, and correction of hematopoietic stem cell aging2
Preclinical studies on the use of a P-selectin-blocking monoclonal antibody to halt progression of myelofibrosis in the Gata1 mouse model2
Macroscopic, histologic, and clinical assessment of acute graft-versus-host disease of the upper gastrointestinal tract within 6 weeks after allogeneic hematopoietic cell transplantation2
Ubiquitin E3 ligase FBXO21 regulates cytokine-mediated signaling pathways, but is dispensable for steady-state hematopoiesis2
A Bloody Feast—Nutritional Regulation of Hematopoiesis2
Activated HoxB4-induced hematopoietic stem cells from murine pluripotent stem cells via long-term programming2
CCL8 deficiency in the host abrogates early mortality of acute graft-versus-host disease in mice with dysregulated IL-6 expression2
Chronic inflammation promotes cancer progression as a second hit2
Fetal sheep support the development of hematopoietic cells in vivo from human induced pluripotent stem cells2
O-GlcNAcylation: Implications in normal and malignant hematopoiesis2
Transfusions with laboratory-grown red blood cells: a new development in science2
Transcriptomic Signatures of Hypomethylating Agent Failure in Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia2
Metabolic regulation of aged hematopoietic stem cells: key players and mechanisms2
Effects of ruxolitinib on murine regulatory T cells are immune-context dependent2
CRLF2 overexpression results in reduced B-cell differentiation and upregulated E2F signaling in the Dp16 mouse model of Down syndrome2
3077 – DO MURINE MSCS EVADE IMMUNE REACTIONS IN VIVO?1
3161 – CELLULAR AND MOLECULAR EFFECTS OF DMPGE₂ RADIOMITIGATION IN MOUSE AND HUMAN BONE MARROW CELLS IN VIVO USING C57BL/6 AND HUMANIZED NSG MOUSE MODELS OF ACUTE RADIATION SYNDROME1
Identification of clonal immunoglobulin λ light-chain gene rearrangements in AL amyloidosis using next-generation sequencing1
3022 – CELL SIZE IS A DETERMINANT OF STEM CELL POTENTIAL DURING AGING1
3020 – RNA-INTERFERENCE SCREEN IDENTIFIES MTA1 AS A REGULATOR OF HUMAN HEMATOPOIETIC STEM AND PROGENITOR CELLS1
AKT2 inhibition accelerates the acquisition of phagocytic ability in induced pluripotent stem cell–derived neutrophils1
To bi or not to bi: Acute erythroid leukemias and hematopoietic lineage choice1
Hematopoietic stem cells depend on HIM and HER1
Specific effects of somatic GATA2 zinc finger mutations on erythroid differentiation1
Trained immunity and epigenetic memory in long-term self-renewing hematopoietic cells1
3083 – THE MURINE BONE MARROW NICHE DOES NOT SUPPORT A DIVERSE ARRAY OF HEMATOPOIETIC STEM AND PROGENITOR CELLS UNTIL BIRTH1
3030 – SECRETOMIC CHARACTERIZATION OF REVITALIZED BONE MARROW STROMAL CELLS IDENTIFIES SEMAPHORIN 3A AND 7A AS POTENTIAL NICHE FACTORS1
IOX1 Fails to Reduce α-Globin and Mediates γ-Globin Silencing in Adult β0-Thalassemia/Hemoglobin E Erythroid Progenitor Cells1
Corrigendum to <Does lineage plasticity enable escape from CAR-T cell therapy? Lessons from MLL-r leukemia’>1
Lineage- and Stage-Specific Oncogenicity of IRF41
3012 – PROBING HEMATOPOIETIC-STROMAL CROSSTALK BY SPATIALLY RESOLVED SINGLE-CELL RNA SEQ1
3218 – CIRCULATING MICRORNAS IN CEREBROSPINAL FLUID AND PLASMA: SENSITIVE TOOL FOR DETECTION OF SECONDARY CNS INVOLVEMENT, MONITORING OF THERAPY AND PREDICTION OF CNS RELAPSE IN AGGRESSIVE B-NHL LYMPH1
Hydroxyurea Decouples Persistent F-Cell Elevation and Induction of γ-Globin1
Epidemiology of Chronic Lymphocytic Leukemia in Sardinia, Italy (1974–2003)1
3137 – ACUTE MYLOID LEUKEMIA KEY MUTATIONS IN THE LENS OF RAMAN MICROSCOPY.1
3227 – STAG2-COHESIN LOSS ATTENUATES FLT3ITD MYELOID BLAST EXPANSION YET PRESERVES MUTANT HSCS1
Assay optimization for the objective quantification of human multilineage colony-forming units1
Targeting positive cofactor 4 induces autophagic cell death in MYC-expressing diffuse large B-cell lymphoma1
Ruxolitinib ameliorates progressive anemia and improves survival during episodes of emergency granulopoiesis in Fanconi C–/– mice1
3095 – IMMUNE THROMBOCYTOPENIA AND BONE MARROW HEMOPHAGOCYTOSIS ASSOCIATED WITH SARS COV-21
Presence of mutant p53 increases stem cell frequency and is associated with reduced binding to classic TP53 binding sites in cell lines and primary AMLs1
Bmi1 induction protects hematopoietic stem cells against pronounced long-term hematopoietic stress1
The YEATS domain epigenetic reader proteins ENL and AF9 and their therapeutic value in leukemia1
Establishment of ganglioside GD2-expressing extranodal NK/T-cell lymphoma cell line with scRNA-seq analysis1
Efficacy and Safety of Replacing Lenalidomide with Pomalidomide for Patients with Multiple Myeloma Refractory to a Lenalidomide-Containing Combination Regimen1
Optimized clinical application of minimal residual disease in acute myeloid leukemia with RUNX1–RUNX1T11
1008 – INTERFERON GAMMA-MEDIATED REGULATION OF HSCS: MECHANISMS AND ROLE IN CLONAL HEMATOPOIESIS.1
3135 – VISIBLE VIOLET-BLUE LIGHT FOR PATHOGEN REDUCTION OF BLOOD PLASMA: ASSESSMENT OF BROAD SPECTRUM ANTIBACTERIAL EFFICACY AND PRELIMINARY COMPATIBILITY STUDIES1
Acute myeloid leukemia exhibiting clonal instability during treatment: Implications for measurable residual disease assessments1
Metabolic regulation in erythroid differentiation by systemic ketogenesis in fasted mice1
3054 – CLINICALLY MEANINGFUL AND LONG-TERM IMPROVEMENTS IN FATIGUE WITH THE C3 INHIBITOR PEGCETACOPLAN IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: A POST HOC ANALYSIS FROM THE PEGASUS TRIAL AT WEEK 481
RNAi Screen Identifies MTA1 as an Epigenetic Modifier of Differentiation Commitment in Human HSPCs1
Cytogenetic and cytokine profile in elderly patients with cytopenia1
3143 – CHARACTERIZATION OF GENOME-WIDE BINDING OF NFIX IN HEMATOPOIETIC CELLS1
Murine double minute X plays a central role in leukemic transformation and may be a promising target for leukemia prevention strategies1
3035 – THE IL1-IL1RAP AXIS PLAYS AN IMPORTANT ROLE IN THE INFLAMMATORY LEUKEMIC NICHE THAT FAVORS ACUTE MYELOID LEUKEMIA CELL PROLIFERATION OVER NORMAL HEMATOPOIESIS1
Posttransplant cyclophosphamide contributes to the impairment of the graft-versus-leukemia effect and the amelioration of graft-versus-host disease with the suppression of alloreactive T cells in a mu1
Proteoglycans regulate protein tyrosine phosphatase receptor σ organization on hematopoietic stem/progenitor cells1
3018 – BIOENGINEERED HUMAN MICROTISSUE MODEL OF HEALTHY AND LEUKEMIC BONE MARROW1
2008 – ADULT HEMATOPOIETIC STEM CELL CLONALITY IS DETERMINED BY EMBRYONIC MACROPHAGE SENSING OF CALRETICULIN1
3195 – LONG-TERM EX VIVO HEMATOPOIETIC STEM CELL (HSC) EXPANSION USING NOVEL BONE-LINING REINVIGORATING MESENCHYMAL STROMAL CELLS (RMSCS)1
0.043523788452148